Dr. Reddy’s Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.
Financial Results:
Dr Reddy’s Laboratories Ltd reported Revenues for Q4FY24 of ₹5,105.00 Crores up from ₹4,554.00 Crore year on year, a rise of 12.1%.
Total Expenses for Q4FY24 of ₹3,978.00 Crores up from ₹3,733.00 Crores year on year, a rise of 6.56%.
Consolidated Net Profit of ₹1,035.00 Crores up 54.02% from ₹672.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹62.03, up 53.62% from ₹40.38 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.